品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

TheNativeAntigenCompany/Dengue Virus Serotype 4 VLP/100µg/DENV4-VLP-100

价格
¥12780.00
货号:DENV4-VLP-100
浏览量:127
品牌:TheNativeAntigenCompany
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Non-reducing SDS-PAGE gel showing purified Dengue virus serotype 4 virus-like particles; envelope protein (E) at approx. 55kDa, and prM protein running at approx. 17-18kDa.

DENGUE VIRUS SEROTYPE 4 VLP

Dengue Virus Serotype 4 VLP (Virus-Like Particle) is a new, unique product that has been developed in response to the need for highly immunogenic, concentrated Dengue antigens for use in Dengue focussed disease research and vaccine development (including use as an immunogen).

PRODUCT DETAILS – DENGUE VIRUS SEROTYPE 4 VLP

  • VLPs are constructed from E, M and preM proteins, with secretion from the cell aided by substituting the C terminal 20% with the corresponding Japanese Encephalitis Virus sequence (all internal/transmembrane).
  • Polyprotein amino acids 400-495 produced in HEK293 expression system and tested for stability.
  • Concentration and purification by a series of ultracentrifugation and chromatographical methods which result in VLPs of exceptional quality and purity.
  • Cleavage of preM protein occurs naturally by furin in the cell and results in a dual population of preM and M-containing VLPs.

BACKGROUND

Virus-Like Particles (VLPs) are an emerging vaccine technology. VLPs consist of protein shells comprising outer proteins specific to the virus in question. VLPs are more representative of how viral antigens are presented in vivo and while they are highly immunogenic they are non-infectious as they lack the core genetic material of the virus. Another important advantage of VLPs is that they more effectively activate key aspects of the immune response to achieve potent immune stimulation and to provide immunological memory. VLP-based vaccines have also shown to provide effective protection and are in current use for several diseases and in development for many others. With more than one-third of the world’s population living in areas at risk of transmission, dengue infection is a leading cause of illness and death in the tropics and subtropics (ref WHO for Guidelines for Diagnosis, Treatment, Prevention & Control, 2009) As many as 100 million people are infected yearly. Dengue is caused by any one of four related viruses transmitted by mosquitoes. There are no vaccines available to prevent infection with dengue virus. Please click here for other serotypes of VLP: Serotype 1, Serotype 2, Serotype 3.

Certificate of AnalysisSafety Datasheet

Publishing research using our reagents? Please let us know so that we can cite your publication as a reference.

1. Metz et al. (2018). Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope. Virol J. 2018 Apr 2;15(1):60 PMID: 29609659

Dry Ice

TheNativeAntigenCompany我们在测定开发方面拥有多年经验。根据具体应用,我们建议并测试多种不同的ELISA格式,从简单的直接ELISA到具有封闭抗原的间接ELISA和双抗原结合ELISA。您不仅可以从我们的高级测定开发科学家那里获得咨询的好处,而且我们的内部表达系统还可以用于生产天然折叠的和完全糖基化的蛋白质和抗体,以用作最高质量的独特试剂,从而使您的ELISA处于优势反对竞争。我们的能力包括:+   ELISA设计和格式咨询+   定制抗原和抗体生产+   使用定制抗原作为免疫原(mAbs和pAbs)产生抗体+   ELISA中的抗原/抗体对优化+   与酶结合以检测抗体+   板涂+   ELISA优化  我们可以在项目的任何阶段为您的ELISA分析的开发提供支持,  提供定制服务,这些灵活性可以评估用于分析的最佳抗体  对,直至商业套件的全面开发。 如果您的概念还处于早期阶段,那么我们可以准备您的抗原,  提高您的抗体,并使用它们来开发特定的ELISA分析以满足您的需求。